Full name
INNOMEDIQ SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.75.Z - Wholesale trade
46.76.Z - Wholesale trade
47.74.Z - Retail sale of medical and orthopedic products
70.22.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
73.11.Z - Advertising agency activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0 | -0,3 | 0,1 | 120,7 |
EBITDA | 0 | -0,2 | 0,1 | 146,3 |
Short time liabilities | 0,2 | 0,9 | 1,2 | 31,4 |
Equity capital | 0 | -0,3 | -0,2 | 20,9 |
Operating profit (EBIT) | 0 | -0,2 | 0,1 | 143,9 |
Assets | 0,6 | 0,6 | 1 | 57,1 |
Net profit (loss) | -0 | -0,3 | 0,1 | 120,7 |
Cash | 0,2 | 0 | 0 | -96,1 |
Liabilities and provisions for liabilities | 0,6 | 0,9 | 1,2 | 31,4 |
Net income from sale | 0,1 | 0,6 | 2 | 238,9 |
Working assets | 0,6 | 0,6 | 1 | 56 |
Depreciation | 0 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | -28,4 | 101,1 | -26,4 | -127,5 |
Equity capital to total assets | 1,3 | -49,3 | -24,8 | 24,5 |
Gross profit margin | -1,5 | -53 | 3,2 | 56,2 |
EBITDA Margin | 9,5 | -42,5 | 5,8 | 48,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 633 | 579 | 225 | -354 |
Current financial liquidity indicator | 3.492166519165039 | |||
Net dept to EBITDA | 26.991914749145508 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane